Allergy Therapeutics plc (LON:AGY – Get Rating)’s stock price passed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of GBX 19.20 ($0.23) and traded as high as GBX 19.75 ($0.24). Allergy Therapeutics shares last traded at GBX 19.75 ($0.24), with a volume of 6,040 shares trading hands.
Allergy Therapeutics Stock Down 1.3 %
The firm has a 50 day simple moving average of GBX 19.25 and a 200-day simple moving average of GBX 21.31. The company has a quick ratio of 3.14, a current ratio of 3.80 and a debt-to-equity ratio of 18.06. The stock has a market cap of £122.38 million and a P/E ratio of -23.75.
Allergy Therapeutics Company Profile
Allergy Therapeutics plc, a biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics.
- The Institutions Hold On To Darden Restaurants International
- What Steelcase’s Earnings Say About the Return to the Office?
- These 3 Big Dividend Payers Also Boast Strong Price Growth
- Is The Golden Age Of Homebuilding Already Over?
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
Receive News & Ratings for Allergy Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allergy Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.